Reduced gap junctional communication among astrocytes in experimental diabetes: Contributions of altered connexin protein levels and oxidative-nitrosative modifications

Journal of Neuroscience Research

Volumn 89, Issue 12, 2011, Pages 2052-2067

  Ball, Kelly K ^a   Harik, Lamia ^a   Gandhi, Gautam K ^a   Cruz, Nancy F ^a   Dienel, Gerald A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Astrocyte; Connexin; Diabetes; Gap junction; Housekeeping proteins; Hyperglycemia; Oxidative nitrosative stress; Streptozotocin; Western blot

Indexed keywords

ACTIN; CONNEXIN 26; CONNEXIN 30; CONNEXIN 43; DITHIOTHREITOL; GAP JUNCTION PROTEIN; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CHEMOLUMINESCENCE; CONTROLLED STUDY; DEPHOSPHORYLATION; EXPERIMENTAL DIABETES MELLITUS; GAP JUNCTION; HYPERGLYCEMIA; INFERIOR COLLICULUS; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CONNEXINS; DIABETES MELLITUS, EXPERIMENTAL; GAP JUNCTIONS; OXIDATIVE STRESS; RATS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 80052800447     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22663     Document Type: Article

References (106)

1. Abe T, Takahashi S, Suzuki N. 2006. Oxidative metabolism in cultured rat astroglia: effects of reducing the glucose concentration in the culture medium and of D-aspartate or potassium stimulation. J Cereb Blood Flow Metab 26: 153-160.
2. Aldridge GM, Podrebarac DM, Greenough WT, Weiler IJ. 2008. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172: 250-254.
3. Alegria-Schaffer A, Lodge A, Vattem K. 2009. Performing and optimizing Western blots with an emphasis on chemiluminescent detection. Methods Enzymol 463: 573-599.
4. Allen KV, Frier BM, Strachan MW. 2004. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490: 169-175.
5. Atkinson MM, Lampe PD, Lin HH, Kollander R, Li XR, Kiang DT. 1995. Cyclic AMP modifies the cellular distribution of connexin43 and induces a persistent increase in the junctional permeability of mouse mammary tumor cells. J Cell Sci 108: 3079-3090.
6. 14C]glucose metabolite trafficking. J Neurosci Res 85: 3267-3283.
7. Bauer DE, Haroutunian V, McCullumsmith RE, Meador-Woodruff JH. 2009. Expression of four housekeeping proteins in elderly patients with schizophrenia. J Neural Transm 116: 487-491.
8. Biessels GJ, Gispen WH. 2005. The impact of diabetes on cognition: what can be learned from rodent models? Neurobiol Aging 26( Suppl 1): 36-41.
9. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. 1998. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res 800: 125-135.
10. Biessels GJ, Cristino NA, Rutten GJ, Hamers FP, Erkelens DW, Gispen WH. 1999. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain 122: 757-768.
11. 2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. Brain Res 1035: 86-93.
12. Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM, Roy S. 2010. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Ophthalmol Vis Sci 51: 3758-3763.
13. Bolaños JP, Medina JM. 1996. Induction of nitric oxide synthase inhibits gap junction permeability in cultured rat astrocytes. J Neurochem 66: 2091-2099.
14. Brands AM, Biessels GJ, Kappelle LJ, de Haan EH, de Valk HW, Algra A, Kessels RP. 2007. Utrecht Diabetic Encephalopathy Study Group. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Disord 23: 343-350.
15. Brissette JL, Kumar NM, Gilula NB, Dotto GP. 1991. The tumor promoter 12-O-tetradecanoylphorbol-13-acetate and the ras oncogene modulate expression and phosphorylation of gap junction proteins. Mol Cell Biol 11: 5364-5371.
16. Brownlee M. 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.
17. Buller N, Laurian N, Shvili I, Laurian L. 1986. Delayed brainstem auditory evoked responses in experimental diabetes mellitus. J Laryngol Otol 100: 883-891.
18. Buller N, Shvili Y, Laurian N, Laurian L, Zohar Y. 1988. Delayed brainstem auditory evoked responses in diabetic patients. J Laryngol Otol 102: 857-860.
19. Burghardt RC, Barhoumi R, Sewall TC, Bowen JA. 1995. Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43. J Membr Biol 148: 243-253.
20. Burt JM, Spray DC. 1988. Inotropic agents modulate gap junctional conductance between cardiac myocytes. Am J Physiol 254: H1206-H1210.
21. Calvo AC, Moreno-Igoa M, Manzano R, Ordovás L, Yagüe G, Oliván S, Muñoz MJ, Zaragoza P, Osta R. 2008. Determination of protein and RNA expression levels of common housekeeping genes in a mouse model of neurodegeneration. Proteomics 8: 4338-4433.
22. Chibber R, Molinatti PA, Kohner EM. 1999. Intracellular protein glycation in cultured retinal capillary pericytes and endothelial cells exposed to high-glucose concentration. Cell Mol Biol 45: 47-57.
23. Contreras JE, Sánchez HA, Eugenin EA, Speidel D, Theis M, Willecke K, Bukauskas FF, Bennett MV, Sáez JC. 2002. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc Natl Acad Sci U S A 99: 495-500.
24. 14C]glucose metabolite spreading and release. J Neurosci Res 85: 3254-3266.
25. DCCT/EDIC (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group), Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J. 2007. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356: 1842-1852.
26. Di Mario U, Morano S, Valle E, Pozzessere G. 1995. Electrophysiological alterations of the central nervous system in diabetes mellitus. Diabetes Metab Rev 11: 259-277.
27. Díaz de León-Morales LV, Jáuregui-Renaud K, Garay-Sevilla ME, Hernández-Prado J, Malacara-Hernández JM. 2005. Auditory impairment in patients with type 2 diabetes mellitus. Arch Med Res 36: 507-510.
28. Dienel GA, Cruz NF. 2008. Imaging brain activation: simple pictures of complex biology. Ann N Y Acad Sci 1147: 139-170.
29. Dittmer A, Dittmer J. 2006. Beta-actin is not a reliable loading control in Western blot analysis. Electrophoresis 27: 2844-2845.
30. Du Y, Sarthy VP, Kern TS. 2004. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am J Physiol Regul Integr Comp Physiol 287: R735-R741.
31. Elfgang C, Eckert R, Lichtenberg-Fraté H, Butterweck A, Traub O, Klein RA, Hülser DF, Willecke K. 1995. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 129: 805-817.
32. Esen N, Tanga FY, DeLeo JA, Kielian T. 2004. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the gram-positive bacterium Staphylococcus aureus. J Neurochem 88: 746-758.
33. Esen N, Shuffield D, Syed MM, Kielian T. 2007. Modulation of connexin expression and gap junction communication in astrocytes by the gram-positive bacterium S. aureus. Glia 55: 104-117.
34. Fernandes R, Girão H, Pereira P. 2004. High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem 279: 27219-27224.
35. Freshhney IR. 2000. Culture of animal cells. A manual of basic technique, 4th ed. New York: Wiley-Liss.
36. Frisina ST, Mapes F, Kim S, Frisina DR, Frisina RD. 2006. Characterization of hearing loss in aged type II diabetics. Hear Res 211: 103-113.
37. Gandhi GK, Ball KK, Cruz NF, Dienel GA. 2010. Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro art:e00030.doi:10.1042/AN20090048.
38. Ghitescu LD, Gugliucci A, Dumas F. 2001. Actin and annexins I and II are among the main endothelial plasmalemma-associated proteins forming early glucose adducts in experimental diabetes. Diabetes 50: 1666-1674.
39. Greer S, Honeywell R, Geletu M, Arulanandam R, Raptis L. 2010. Housekeeping genes; expression levels may change with density of cultured cells. J Immunol Methods 355: 76-79.
40. Gross PM, Sposito NM, Pettersen SE, Panton DG, Fenstermacher JD. 1987. Topography of capillary density, glucose metabolism, and microvascular function within the rat inferior colliculus. J Cereb Blood Flow Metab 7: 154-160.
41. Hamby ME, Uliasz TF, Hewett SJ, Hewett JA. 2006. Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. J Neurosci Methods 150: 128-137.
42. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. 2003. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 9: 294-299.
43. Hara MR, Snyder SH. 2006. Nitric oxide-GAPDH-Siah: a novel cell death cascade. Cell Mol Neurobiol 26: 527-538.
44. Hara MR, Cascio MB, Sawa A. 2006. GAPDH as a sensor of NO stress. Biochim Biophys Acta 1762: 502-509.
45. Hertz L, Peng L, Lai JC. 1998. Functional studies in cultured astrocytes. Methods 16: 293-310.
46. Hossain MZ, Murphy LJ, Hertzberg EL, Nagy JI. 1994. Phosphorylated forms of connexin43 predominate in rat brain: demonstration by rapid inactivation of brain metabolism. J Neurochem 62: 2394-2403.
47. Howarth FC, Chandler NJ, Kharche S, Tellez JO, Greener ID, Yamanushi TT, Billeter R, Boyett MR, Zhang H, Dobrzynski H. 2008. Effects of streptozotocin-induced diabetes on connexin43 mRNA and protein expression in ventricular muscle. Mol Cell Biochem 319: 105-114.
48. Huber JD, VanGilder RL, Houser KA. 2006. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol 291: H2660-H2668.
49. Inoguchi T, Ueda F, Umeda F, Yamashita T, Nawata H. 1995. Inhibition of intercellular communication via gap junction in cultured aortic endothelial cells by elevated glucose and phorbol ester. Biochem Biophys Res Commun 208: 492-497.
50. Kamal A, Biessels GJ, Urban IJ, Gispen WH. 1999. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 90: 737-745.
51. Kamal A, Biessels GJ, Gispen WH, Ramakers GM. 2006. Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats. Brain Res 1073/1074: 276-280.
52. Kanwar M, Kowluru RA. 2009. Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy. Diabetes 58: 227-234.
53. Kleman AM, Yuan JY, Aja S, Ronnett GV, Landree LE. 2008. Physiological glucose is critical for optimized neuronal viability and AMPK responsiveness in vitro. J Neurosci Methods 167: 292-301.
54. Kodl CT, Seaquist ER. 2008. Cognitive dysfunction and diabetes mellitus. Endocr Rev 29: 494-511.
55. Kornberg MD, Sen N, Hara MR, Juluri KR, Nguyen JV, Snowman AM, Law L, Hester LD, Snyder SH. 2010. GAPDH mediates nitrosylation of nuclear proteins. Nat Cell Biol 12: 1094-1100.
56. Kuroki T, Inoguchi T, Umeda F, Ueda F, Nawata H. 1998. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes 47: 931-936.
57. Kusner LL, Sarthy VP, Mohr S. 2004. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Müller cells. Invest Ophthalmol Vis Sci 45: 1553-1561.
58. Lampe PD, Lau AF. 2004. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36: 1171-1186.
59. Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV. 2007. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48: 5257-5265.
60. Li AF, Sato T, Haimovici R, Okamoto T. 2003. High glucose alters connexin 43 expression and gap junction intercellular communication activity in retinal pericytes. Invest Ophthalmol Vis Sci 44: 5376-5382.
61. Li W, Hertzberg EL, Spray DC. 2005. Regulation of connexin43-protein binding in astrocytes in response to chemical ischemia/hypoxia. J Biol Chem 280: 7941-7948.
62. Li WE, Nagy JI. 2000. Connexin43 phosphorylation state and intercellular communication in cultured astrocytes following hypoxia and protein phosphatase inhibition. Eur J Neurosci 12: 2644-2650.
63. Lin H, Ogawa K, Imanaga I, Tribulova N. 2006. Remodeling of connexin 43 in the diabetic rat heart. Mol Cell Biochem 290: 69-78.
64. Little AA, Edwards JL, Feldman EL. 2007. Diabetic neuropathies. Pract Neurol 7: 82-92.
65. Liu NK, Xu XM. 2006. Beta-tubulin is a more suitable internal control than beta-actin in Western blot analysis of spinal cord tissues after traumatic injury. J Neurotrauma 23: 1794-1801.
66. Makino A, Platoshyn O, Suarez J, Yuan JX, Dillmann WH. 2008. Downregulation of connexin40 is associated with coronary endothelial cell dysfunction in streptozotocin-induced diabetic mice. Am J Physiol Cell Physiol 295: C221-C230.
67. Malfait M, Gomez P, van Veen TA, Parys JB, De Smedt H, Vereecke J, Himpens B. 2001. Effects of hyperglycemia and protein kinase C on connexin43 expression in cultured rat retinal pigment epithelial cells. J Membr Biol 181: 31-40.
68. Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ. 2003. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabeticrats: effects of treatment with an angiotensin converting enzyme inhibitor. Diabetes Metab Res Rev 19: 469-477.
69. Manschot SM, Biessels GJ, Rutten GE, Kessels RC, Gispen WH, Kappelle LJ, Utrecht Diabetic Encephalopathy Study Group. 2008. Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J Neurol Sci 264: 157-162.
70. Manthey D, Banach K, Desplantez T, Lee CG, Kozak CA, Traub O, Weingart R, Willecke K. 2001. Intracellular domains of mouse connexin26 and -30 affect diffusional and electrical properties of gap junction channels. J Membrane Biol 181: 137-148.
71. McCall AL. 1992. The impact of diabetes on the CNS. Diabetes 41: 557-570.
72. McCall AL. 2004. Cerebral glucose metabolism in diabetes mellitus. Eur J Pharmacol 490: 147-158.
73. McCall AL. 2005. Altered glycemia and brain-update and potential relevance to the aging brain. Neurobiol Aging 26( Suppl 1): 70-75.
74. Mîinea C, Kuruvilla R, Merrikh H, Eichberg J. 2002. Altered arachidonic acid biosynthesis and antioxidant protection mechanisms in Schwann cells grown in elevated glucose. J Neurochem 81: 1253-1262.
75. Mooradian AD. 1997. Pathophysiology of central nervous system complications in diabetes mellitus. Clin Neurosci 4: 322-326.
76. Nagy JI, Rash JE. 2000. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Brain Res Rev 32: 29-44.
77. Nagy JI, Li X, Rempel J, Stelmack G, Patel D, Staines WA, Yasumura T, Rash JE. 2001. Connexin26 in adult rodent central nervous system: demonstration at astrocytic gap junctions and colocalization with connexin30 and connexin43. J Comp Neurol 441: 302-323.
78. Oku H, Kodama T, Sakagami K, Puro DG. 2001. Diabetes-induced disruption of gap junction pathways within the retinal microvasculature. Invest Ophthalmol Vis Sci 42: 1915-1920.
79. Paulson AF, Lampe PD, Meyer RA, TenBroek E, Atkinson MM, Walseth TF, Johnson RG. 2000. Cyclic AMP and LDL trigger a rapid enhancement in gap junction assembly through a stimulation of connexin trafficking. J Cell Sci 113: 3037-3049.
80. Prime G, Horn G, Sutor B. 2000. Time-related changes in connexin mRNA abundance in the rat neocortex during postnatal development. Brain Res Dev Brain Res 119: 111-125.
81. Rash JE, Yasumura T, Dudek FE, Nagy JI. 2001. Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J Neurosci 21: 1983-2000.
82. Retamal MA, Cortés CJ, Reuss L, Bennett MV, Sáez JC. 2006. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc Natl Acad Sci U S A 103: 4475-4480.
83. Retamal MA, Schalper KA, Shoji KF, Bennett MV, Sáez JC. 2007. Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential. Proc Natl Acad Sci U S A 104: 8322-8327.
84. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC. 2008. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 65: 1066-1073.
85. Romero-Calvo I, Ocón B, Martínez-Moya P, Suárez MD, Zarzuelo A, Martínez-Augustin O, de Medina FS. 2010. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401: 318-320.
86. Rubini R, Biasiolo F, Fogarolo F, Magnavita V, Martini A, Fiori MG. 1992. Brainstem auditory evoked potentials in rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract 16: 19-25.
87. Saez JC, Spray DC, Nairn AC, Hertzberg E, Greengard P, Bennett MV. 1986. cAMP increases junctional conductance and stimulates phosphorylation of the 27-kDa principal gap junction polypeptide. Proc Natl Acad Sci U S A 83: 2473-2477.
88. Sato T, Haimovici R, Kao R, Li AF, Roy S. 2002. Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes 51: 1565-1571.
89. Schousboe A, Nissen C, Bock E, Sapirstein VS, Juurlink BHJ, Hertz L 1980. Biochemical development of rodent astrocytes in primary cultures. In: Giacobini E, Vermadalos A, Shahar A, editors. Tissue culture in neurobiology. New York: Raven Press. p 397-410.
90. Sen N, Hara MR, Ahmad AS, Cascio MB, Kamiya A, Ehmsen JT, Agrawal N, Hester L, Doré S, Snyder SH, Sawa A. 2009. GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation. Neuron 63: 81-91.
91. Sima AA, Kamiya H, Li ZG. 2004. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 490: 187-197.
92. Simmons ML, Murphy S. 1992. Induction of nitric oxide synthase in glial cells. J Neurochem 59: 897-905.
93. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897-916.
94. Spray DC, Moreno AP, Kessler JA, Dermietzel R. 1991. Characterization of gap junctions between cultured leptomeningeal cells. Brain Res 568: 1-14.
95. Stalmans P, Himpens B. 1997. Effect of increasing glucose concentrations and protein phosphorylation on intercellular communication in cultured rat retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 38: 1598-1609.
96. Straub AC, Billaud M, Johnstone SR, Best AK, Yemen S, Dwyer ST, Looft-Wilson R, Lysiak JJ, Gaston B, Palmer L, Isakson BE. 2010. Compartmentalized connexin 43 S-nitrosylation/denitrosylation regulates heterocellular communication in the vessel wall. Arterioscler Thromb Vasc Biol Nov 11. DOI: 10.1161/ATVBAHA.110.215939 [E-pub ahead of print].
97. Suadicani SO, Urban-Maldonado M, Tar MT, Melman A, Spray DC. 2009. Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder. BJU Int 103: 1686-1693.
98. Tay HL, Ray N, Ohri R, Frootko NJ. 1995. Diabetes mellitus and hearing loss. Clin Otolaryngol Allied Sci 20: 130-134.
99. TenBroek EM, Lampe PD, Solan JL, Reynhout JK, Johnson RG. 2001. Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J Cell Biol 155: 1307-1318.
100. Thi MM, Urban-Maldonado M, Spray DC, Suadicani SO. 2010. Intercellular communication among astrocytes is enhanced by high glucose exposure in culture. Trans Am Soc Neurochem, vol 106.
101. Tristan C, Shahani N, Sedlak TW, Sawa A. 2010. The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal [Aug 19 E-pub ahead of print].
102. Vaughan N, James K, McDermott D, Griest S, Fausti S. 2006. A 5-year prospective study of diabetes and hearing loss in a veteran population. Otol Neurotol 27: 37-43.
103. Vaughan N, James K, McDermott D, Griest S, Fausti S. 2007. Auditory brainstem response differences in diabetic and non-diabetic veterans. J Am Acad Audiol 18: 863-871.
104. Weldon S, Ambroz K, Schutz-Geschwender A, Olive DM. 2008. Near-infrared fluorescence detection permits accurate imaging of loading controls for Western blot analysis. Anal Biochem 375: 156-158.
105. Yego EC, Mohr S. 2010. siah-1 Protein is necessary for high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation and cell death in Muller cells. J Biol Chem 285: 3181-3190.
106. Yego EC, Vincent JA, Sarthy V, Busik JV, Mohr S. 2009. Differential regulation of high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation in Müller cells by IL-1beta and IL-6. Invest Ophthalmol Vis Sci 50: 1920-1928.